Adicet Bio, Inc. (ACET)
9.59
+0.16
(+1.70%)
USD |
NASDAQ |
Sep 04, 16:00
9.63
+0.04
(+0.42%)
Pre-Market: 20:00
Adicet Bio Price : 9.59 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 9.33 | 9.76 | 9.261 | 9.59 | 44609.00 |
| Sep 03, 2026 | 9.26 | 9.64 | 9.048 | 9.43 | 78757.00 |
| Sep 02, 2026 | 9.35 | 9.65 | 9.001 | 9.26 | 60955.00 |
| Sep 01, 2026 | 8.87 | 9.45 | 8.77 | 9.26 | 134127.0 |
| Aug 31, 2026 | 8.92 | 9.07 | 8.62 | 8.70 | 112001.0 |
| Aug 28, 2026 | 9.22 | 9.245 | 8.76 | 9.06 | 111654.0 |
| Aug 27, 2026 | 9.00 | 9.18 | 8.841 | 9.01 | 261593.0 |
| Aug 26, 2026 | 8.98 | 9.04 | 8.63 | 8.95 | 119340.0 |
| Aug 25, 2026 | 8.98 | 9.145 | 8.78 | 9.00 | 69875.00 |
| Aug 24, 2026 | 9.21 | 9.21 | 8.74 | 8.90 | 64334.00 |
| Aug 21, 2026 | 9.42 | 9.63 | 9.10 | 9.19 | 80499.00 |
| Aug 20, 2026 | 9.616 | 9.647 | 9.08 | 9.38 | 65528.00 |
| Aug 19, 2026 | 8.99 | 9.60 | 8.99 | 9.49 | 84849.00 |
| Aug 18, 2026 | 8.75 | 9.22 | 8.70 | 9.11 | 101413.0 |
| Aug 17, 2026 | 8.46 | 8.99 | 8.46 | 8.74 | 93226.00 |
| Aug 14, 2026 | 8.30 | 8.38 | 8.15 | 8.38 | 57936.00 |
| Aug 13, 2026 | 8.35 | 8.50 | 8.25 | 8.26 | 51263.00 |
| Aug 12, 2026 | 8.30 | 8.35 | 8.18 | 8.26 | 39850.00 |
| Aug 11, 2026 | 8.15 | 8.29 | 7.925 | 8.23 | 65757.00 |
| Aug 10, 2026 | 7.96 | 8.23 | 7.85 | 8.11 | 85812.00 |
| Aug 07, 2026 | 8.12 | 8.300 | 7.98 | 7.98 | 80453.00 |
| Aug 06, 2026 | 8.71 | 8.88 | 7.42 | 7.93 | 179951.0 |
| Aug 05, 2026 | 9.31 | 9.50 | 9.005 | 9.16 | 43379.00 |
| Aug 04, 2026 | 9.35 | 9.47 | 9.19 | 9.21 | 95401.00 |
| Aug 03, 2026 | 9.08 | 9.835 | 9.00 | 9.24 | 135437.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 28.02 |
| Alnylam Pharmaceuticals, Inc. | 266.11 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.19 |
Price Related Metrics
| PEG Ratio | -0.2701 |
| Price to Book Value | 0.7473 |
| Earnings Yield | -120.3% |
| Market Cap | 89.78M |
| PEGY Ratio | -0.2701 |